| Title |
Author |
Type |
Date |
Words |
| Hinsdale-Based Visible Genomics Announces Four New Appointments to Board of Clinical Advisors. |
Creative Marketing Associates |
|
Oct 6, 2020 |
420 |
| Eye up challenge for your health. |
|
|
Oct 5, 2020 |
199 |
| Novartis Notes Phase III Trial Showing Improved Beovu Treatment. |
|
|
Oct 5, 2020 |
221 |
| Kodiak Sciences: First patients treated in Phase 3 Studies of KSI-301. |
|
|
Oct 5, 2020 |
156 |
| Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment of Retinitis Pigmentosa. |
|
|
Oct 5, 2020 |
620 |
| Apellis announces results of post hoc analysis of Phase 2 FILLY study. |
|
|
Oct 4, 2020 |
238 |
| Lineage Cell Therapeutics busy working on treatments relating to Dry AMD and spinal cord injury. |
|
|
Oct 2, 2020 |
158 |
| Astellas Pharma collaborates with University of Pittsburgh. |
|
|
Sep 25, 2020 |
257 |
| Astellas Pharma collaborates with University of Pittsburgh. |
|
|
Sep 25, 2020 |
253 |
| Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration. |
|
|
Sep 22, 2020 |
300 |
| Bausch Health to Acquire Option to Purchase All Ophthalmology Assets of Allegro Ophthalmics. |
|
|
Sep 21, 2020 |
404 |
| Visible Genomics launches DNA age-related macular degeneration testing. |
Submitted by Creative Marketing Associates |
|
Sep 17, 2020 |
541 |
| Visible Genomics Launches DNA Age-Related Macular Degeneration Testing. |
Creative Marketing Associates |
|
Sep 16, 2020 |
547 |
| Readers continue to worry about COVID-19 Doctors: Soft drusen can lead to macular degeneration. |
|
|
Sep 14, 2020 |
1009 |
| Drusen severity depends on the type. |
Dr. Eve Glazier and Dr. Elizabeth Ko |
|
Sep 14, 2020 |
554 |
| New Understanding of Genetic Changes in the Eye. |
|
|
Aug 26, 2020 |
209 |
| Outlook Therapeutics reports topline results from NORSE 1 study. |
|
|
Aug 26, 2020 |
432 |
| Gyroscope Therapeutics Initiates Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration. |
|
|
Aug 13, 2020 |
671 |
| Kodiak Sciences reports Q2 EPS (58c), consensus (66c). |
|
Financial report |
Aug 10, 2020 |
395 |
| Regenxbio sees starting RGX-314 subretinal delivery pivotal program by end 2020. |
|
|
Aug 4, 2020 |
256 |
| OCT findings in age-related macular degeneration. |
Epshtein, Daniel |
|
Aug 1, 2020 |
599 |
| Novartis Sees Positive Beovu Analysis Results; Sandoz Plans Investment. |
|
|
Jul 27, 2020 |
386 |
| Clearside Biomedical announces multiple presentations at ASRS Annual Meeting. |
|
|
Jul 27, 2020 |
636 |
| NGM Biopharmaceuticals initiates Phase 2 CATALINA study of NGM621. |
|
|
Jul 27, 2020 |
210 |
| Genentech says Archway study data supports 'favorable' benefit-risk profile. |
|
|
Jul 22, 2020 |
468 |
| Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
Francesca Marchetti |
|
Jul 21, 2020 |
1054 |
| Keep an eye on the light and your sight; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
Francesca Marchetti |
|
Jul 21, 2020 |
778 |
| Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
|
|
Jul 21, 2020 |
1050 |
| Blind ex-Navy man urges runners to join in challenge. |
LISA O'BRIEN lisa.obrien@mnamedia.co.uk |
|
Jul 11, 2020 |
370 |
| Kodiak Sciences reports 'promising' safety data from KSI-301 Phase 1b study. |
|
|
Jul 10, 2020 |
283 |
| First Patient Dosed in Second Zimura Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration. |
|
|
Jul 2, 2020 |
513 |
| Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration. |
Urban, Beata; Szwabowicz, Magdalena; Bakunowicz-Lazarczyk, Alina |
|
Jun 30, 2020 |
5135 |
| Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization. |
Zhang, Xiaoli; Zhu, Manhui; Xie, Laiqing; Sun, Xiaodong; Xu, Jiaowen; Guo, Yang; Liu, Dong; Shi, Yun |
|
Jun 30, 2020 |
7087 |
| Bioinformatical Analysis of miRNA-mRNA Interaction Network Underlying Macrophage Aging and Cholesterol-Responsive Difference between Young and Aged Macrophages. |
Li, Jianqing; Yin, Xue; Zhang, Bingyu; Li, Chen; Lu, Peirong |
|
Jun 30, 2020 |
4909 |
| Lineage Re-Starts Enrollment In Clinical Study Of Treatment For Dry AMD. |
|
|
Jun 29, 2020 |
845 |
| Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. |
|
|
Jun 26, 2020 |
188 |
| Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. |
|
|
Jun 26, 2020 |
184 |
| Lineage Cell Therapeutics reinitiates patient enrollment in OpRegen study. |
|
Clinical report |
Jun 18, 2020 |
176 |
| Clearside Biomedical announce presentations at ARVO 2020 meeting. |
|
|
Jun 17, 2020 |
529 |
| Outlook Therapeutics expects topline results from NORSE 1 study in August. |
|
|
Jun 17, 2020 |
510 |
| Iveric bio announces 18-month Zimura trial data. |
|
|
Jun 15, 2020 |
451 |
| Regeneration Of Retinal Tissue In Dry AMD Patient. |
|
|
Jun 15, 2020 |
709 |
| Novartis Adds Warning To Beovu Label In US After Safety Reports. |
|
|
Jun 11, 2020 |
403 |
| Lineage Cell Therapeutics reports findings from OpRegen study. |
|
|
Jun 1, 2020 |
330 |
| Apigenin Protects Mouse Retina against Oxidative Damage by Regulating the Nrf2 Pathway and Autophagy. |
Zhang, Yuanzhong; Yang, Yan; Yu, Haitao; Li, Min; Hang, Li; Xu, Xinrong |
|
May 31, 2020 |
7386 |
| Roche Reports Positive Results From Third-Phase Archway Study. |
|
|
May 27, 2020 |
194 |
| Genentech says Phase III Archway study met primary endpoint. |
|
|
May 27, 2020 |
232 |
| Charity's tech efforts hailed by blind veteran. |
DAVID PROCTOR |
|
May 23, 2020 |
474 |
| New Data On Treatment of Dry AMD With Geographic Atrophy. |
|
|
May 18, 2020 |
348 |
| Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide. |
|
|
May 14, 2020 |
351 |
| Guardion says Lumega-Z demonstrates superiority in head-to-head study. |
|
|
May 12, 2020 |
246 |
| Lineage Cell Therapeutics announces updated results from OpRegen study. |
|
|
May 6, 2020 |
457 |
| Adverum Biotechnologies reports positive vata in OPTIC ph1 trial of ADVM-022. |
|
|
May 4, 2020 |
174 |
| An Integrative Medical Approach to Macular Degeneration--Part 2. |
Grossman, Marc |
|
May 1, 2020 |
4049 |
| Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments. |
Furino, Claudio; Grassi, Maria Oliva; Bini, Vito; Nacucchi, Annalisa; Boscia, Francesco; Reibaldi, M |
|
Apr 30, 2020 |
2982 |
| Four-Year Outcome of Aflibercept Treatment-Naive Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting. |
Gayadine-Harricham, Yanel; Rufin, Virginie; Law-Koune, Sandrine; Tran, Thi Ha Chau |
|
Apr 30, 2020 |
5196 |
| Adverum Biotechnologies doses first patient in cohort 4 of OPTIC Phase 1 trial. |
|
|
Apr 27, 2020 |
242 |
| Scientists identify the cause of leakiness in eye diseases. |
|
|
Apr 23, 2020 |
343 |
| Regenxbio provides long-term RGX-314 trial data. |
|
|
Apr 22, 2020 |
708 |
| Outlook Therapeutics sees no COVID-19 impact on NORSE 1, delays to NORSE 2. |
|
|
Apr 14, 2020 |
246 |
| Mother It looks lik ke it's good for you; Mother Nature is trying to tell us something about the health benefits of fruit, vegetables and other foods - but have you spotted the clues? Jane Symons has. |
|
|
Apr 7, 2020 |
1563 |
| It looks like it's good for you; HEALTH be your best Edited by AMY PACKER yourhealth@mirror.co.ukIt seems Mother Nature is trying to tell us something about the health benefits of fruit, vegetables and other foods -- but have you spotted the clues? Jane Symons has. |
AMY PACKER |
|
Apr 7, 2020 |
1523 |
| It looks like it's good for you; HEALTH be your best Edited by AMY PACKER yourhealth@mirror.co.uk It seems Mother Nature is trying to tell us something about the health benefits of fruit, vegetables and other foods but have you spotted the clues? Jane Symons has. |
AMY PACKER |
|
Apr 7, 2020 |
1523 |
| US FDA Grants Fast Track Designation for Zimura for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration. |
|
|
Apr 6, 2020 |
484 |
| Saffron and Macular Degeneration. |
Klotter, Jule |
Clinical report |
Apr 1, 2020 |
282 |
| Can Flavonoids Prevent Age-Related Macular Degeneration? |
Gaby, Alan R. |
Clinical report |
Apr 1, 2020 |
371 |
| An Integrative Medical Approach to Macular Degeneration: Part 1. |
Grossman, Marc |
|
Apr 1, 2020 |
5310 |
| Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan. |
Lo, Kang-Jung; Chang, Jin-Yu; Chang, Hsin-Yi; Chiou, Shih-Hwa; Hwang, De-Kuang; Chen, Shih-Jen |
|
Mar 31, 2020 |
5595 |
| Iveric bio delays initiation of enrollment for Zimura pivotal clinical trial. |
|
|
Mar 18, 2020 |
265 |
| Kodiak Sciences reports Q4 EPS (40c), consensus (35c). |
|
Financial report |
Mar 16, 2020 |
156 |
| Fears over rise in region's residents suffering sight loss. |
|
|
Mar 13, 2020 |
429 |
| TRACON Pharmaceuticals and Santen halt development of DE-122 for wet age-related macular degeneration. |
|
|
Mar 11, 2020 |
473 |
| Anti-Vascular Endothelial Growth Factors as a Potential Risk for Implant Failure: A Clinical Report. |
Emami, Elham; de Grandmont, Pierre; Menassa, Melanie; Audy, Nicholas; Durand, Robert |
Clinical report |
Mar 1, 2020 |
2302 |
| Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab. |
Bilgic, Alper; Kodjikian, Laurent; Chhablani, Jay; Sudhalkar, Anand; Trivedi, Megha; Vasavada, Viraj |
|
Mar 1, 2020 |
6598 |
| Seven-Year Visual and Anatomical Outcomes of Intravitreal Vascular Endothelial Growth Factor Inhibition for Neovascular Age-Related Macular Degeneration. |
Stattin, Martin; Forster, Julia; Ahmed, Daniel; Haas, Anna-Maria; Graf, Alexandra; Krepler, Katharin |
|
Mar 1, 2020 |
4267 |
| Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence from a Review of the Molecular Mechanisms and Animal Models. |
Abokyi, Samuel; To, Chi-Ho; Lam, Tim T.; Tse, Dennis Y. |
Report |
Mar 1, 2020 |
16661 |
| Unhealthy Eating Linked to Risk of Aging-Eye Disease. |
|
|
Feb 28, 2020 |
197 |
| Encouraging News About Macular Degeneration: Blindness from certain forms of this condition can be slowed and sometimes reversed. It's also often misdiagnosed. |
|
|
Feb 28, 2020 |
1166 |
| Gemini Therapeutics and Singapore Eye Research Institute Team to Explore New Targets for Age-related Macular Degeneration. |
|
|
Feb 28, 2020 |
575 |
| First Subject Injected in Phase 2 Clinical Trial of RBM-007 (TOFU Study) in Subjects with Wet Age-Related Macular Degeneration. |
|
|
Feb 25, 2020 |
446 |
| Positive Update On Phase 1/2a Clinical Study Of Treatment For Dry AMD: Company Expects Accelerated Patient Enrollment. |
|
|
Feb 24, 2020 |
573 |
| Discovery could help treat type of blindness. |
|
|
Feb 11, 2020 |
313 |
| Protein discovery offers hope for blindness treatment. |
|
|
Feb 8, 2020 |
159 |
| "Notable Improvements" In Study Of Treatment For Dry AMD. |
|
Clinical report |
Jan 13, 2020 |
433 |
| Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry Age-related Macular Degeneration. |
|
|
Jan 13, 2020 |
457 |
| SECOND SIGHT: A TINY TELESCOPE IS RESTORING VISION FOR MACULAR DEGENERATION PATIENTS. |
Wallace, Hannah |
|
Jan 1, 2020 |
1403 |
| Remember when ... |
|
|
Jan 1, 2020 |
687 |
| Calcium May Decrease Risk of Age-Related Macular Degeneration. |
|
|
Jan 1, 2020 |
185 |
| Multimodal Retinal Image Analysis via Deep Learning for the Diagnosis of Intermediate Dry Age-Related Macular Degeneration: A Feasibility Study. |
Vaghefi, Ehsan; Hill, Sophie; Kersten, Hannah M.; Squirrell, David |
|
Jan 1, 2020 |
4475 |
| Cathepsin B pH-Dependent Activity Is Involved in Lysosomal Dysregulation in Atrophic Age-Related Macular Degeneration. |
Voisin, Audrey; Monville, Christelle; Plancheron, Alexandra; Bere, Emile; Gaillard, Afsaneh; Levezie |
|
Dec 31, 2019 |
7925 |
| Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture. |
Mahmoudian-Sani, Mohammad-Reza; Forouzanfar, Fatemeh; Asgharzade, Samira; Ghorbani, Nilufar |
|
Dec 31, 2019 |
5049 |
| Detection Rate and Diagnostic Value of Optical Coherence Tomography Angiography in the Diagnosis of Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. |
Wang, Yuelin; Yang, Jingyuan; Li, Bing; Yuan, Mingzhen; Chen, Youxin |
|
Dec 31, 2019 |
5790 |
| Effect of oral eplerenone in anatomical and functional improvement in patients with chronic central serous chorioretinopathy. |
Omer Farooq, Asad Habib, Masood Alam Shah and Najia Ahmed |
|
Dec 31, 2019 |
2404 |
| Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy. |
Hina Loya, Hunain Ghoghari, Syed Fawad Rizvi and Abdullah Khan |
|
Dec 31, 2019 |
2446 |
| Brain can combine natural, artificial vision to help treat common form of blindness. |
ANI |
|
Dec 30, 2019 |
489 |
| Scientists inch closer to effective treatment of Macular degeneration. |
ANI |
|
Dec 27, 2019 |
294 |
| Let's cherish NHS and social care.. our lights in darkness; The devastation of failing sight is dimmed by the dedication of medical staff and council workers helping families in need. |
ANNIE BROWN A.BROWN@DAILYRECORD.CO.UK TWITTER: @ANNIEBROWNWORD |
|
Dec 18, 2019 |
1079 |
| What You Eat Could Help Prevent Vision Loss. |
Seema Prasad |
|
Dec 17, 2019 |
472 |
| Poor diet increases risk of vision loss in later life. |
|
|
Dec 14, 2019 |
372 |
| Poor diet increases risk of vision loss in later life. |
|
|
Dec 14, 2019 |
372 |
| Western Diet Linked to Late Age-Related Macular Degeneration; No significant association found between dietary pattern and incidence of any AMD, early AMD. |
|
|
Dec 13, 2019 |
269 |
| Limit Vision Loss From Age-Related Macular Degeneration: Regular eye exams are a must for detecting AMD; the earlier it's diagnosed, the sooner you can take steps to protect your vision. |
|
|
Dec 1, 2019 |
1065 |
| Causes of Blindness and Moderate to Severe Visual Impairment in Nigde, Central Anatolia, Turkey. |
Kucuk, Erkut; Zor, Kursad Ramazan; Yilmaz, Ugur |
|
Dec 1, 2019 |
4242 |
| Protect Eyes from Screen-Time Damage. |
McNeil, Jason |
|
Dec 1, 2019 |
2395 |
| Association between Metformin and a Lower Risk of Age-Related Macular Degeneration in Patients with Type 2 Diabetes. |
Chen, Yu-Yen; Shen, Ying-Cheng; Lai, Yun-Ju; Wang, Chun-Yuan; Lin, Keng-Hung; Feng, Shih-Chao; Liang |
|
Nov 30, 2019 |
5871 |
| An Alternative Psychophysical Diagnostic Indicator of the Aging Eye. |
Rodriguez, John D.; Wallstrom, Garrick; Narayanan, Divya; Welch, Donna; Abelson, Mark B. |
|
Nov 30, 2019 |
3831 |
| A Solid Dispersion of Quercetin Shows Enhanced Nrf2 Activation and Protective Effects against Oxidative Injury in a Mouse Model of Dry Age-Related Macular Degeneration. |
Shao, Yan; Yu, Haitao; Yang, Yan; Li, Min; Hang, Li; Xu, Xinrong |
|
Nov 30, 2019 |
6499 |
| Global Macular Degeneration Treatment Markets: Review & Forecast, 2016-2018 & 2026. |
|
|
Nov 25, 2019 |
1093 |
| Age-related macular degeneration likely to cause central vision loss: Study. |
ANI |
|
Nov 24, 2019 |
398 |
| Global Age-Related Macular Degeneration (AMD) Market Report 2019: Covers Historic & Future Industry Data for the Period 2016-2026. |
|
Report |
Nov 20, 2019 |
653 |
| Researchers predict rise in sight loss; Health: Age-related condition warning. |
JANE KIRBY |
|
Nov 12, 2019 |
255 |
| Applied Genetic announces Stargardt disease as preclinical ophthalmology program. |
|
|
Nov 5, 2019 |
367 |
| Eye care consumers seek out homeopathic products. |
|
|
Nov 4, 2019 |
1701 |
| Focal Choroidal Elevations: Localized Pigment Epithelial Contour Alterations due to Isolated Choroidal Vessels. |
Chu, Rachel L.; Pannullo, Nicole A.; Sigler, Eric J. |
|
Oct 31, 2019 |
3656 |
| One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial. |
Wang, Fenghua; Yuan, Yuanzhi; Wang, Ling; Ye, Xiaofeng; Zhao, Jingke; Shen, Mengxi; Zhang, Qi; Xu, D |
Clinical report |
Oct 31, 2019 |
4404 |
| Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice. |
Garcia-Layana, A.; Garcia-Arumi, J.; Figueroa, M.S.; Barquet, L. Arias; Ruiz-Moreno, J.M.; Monclus-A |
|
Oct 31, 2019 |
6094 |
| Age-Related Macular Degeneration Market visualized increasing with 7.8 % CAGR and reach around USD 11,186.8 Million between 2019 and 2023. |
|
|
Oct 28, 2019 |
979 |
| IVERIC bio says Phase 2 trial of Zimura met primary endpoint. |
|
|
Oct 28, 2019 |
277 |
| Allergan plc (NYSE: AGN) - Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration -- 11/10/2019. |
|
|
Oct 15, 2019 |
602 |
| Allergan plc (NYSE: AGN) - Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration -- 11/10/2019. |
|
|
Oct 14, 2019 |
602 |
| Gene therapy effective for treating wet age-related macular degeneration: Study. |
ANI |
|
Oct 14, 2019 |
522 |
| Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies. |
|
|
Oct 13, 2019 |
201 |
| Adverum Biotechnologies reports additional data from Phase 1 trial of ADVM-022. |
|
|
Oct 13, 2019 |
474 |
| Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301. |
|
|
Oct 13, 2019 |
363 |
| US FDA approves Novartis' Beovu injection. |
|
|
Oct 10, 2019 |
196 |
| US FDA approves Novartis' Beovu injection. |
|
|
Oct 10, 2019 |
192 |
| Boehringer Ingelheim--Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases--20/9/2019. |
|
|
Oct 2, 2019 |
443 |
| Tax on food supplements a 'massive mistake'. |
AILBHE DALY |
|
Oct 2, 2019 |
118 |
| The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey. |
Mirza, Enver; Mirza, Gunsu Deniz; Oltulu, Refik; Okka, Mehmet; Ozkagnici, Ahmet |
|
Oct 1, 2019 |
3913 |
| Long-term exposure to vehicle exhaust linked to AMD. |
Powell, Selina |
|
Oct 1, 2019 |
191 |
| INTELLIGENT RETINAL SCREENING. |
|
|
Oct 1, 2019 |
395 |
| Pueraria lobata Extract Protects Hydrogen Peroxide-Induced Human Retinal Pigment Epithelial Cells Death and Membrane Permeability. |
Rang, Nu Ri; Pyun, Bo-Jeong; Jung, Dong Ho; Lee, Ik Soo; Kim, Chan-Sik; Kim, Young Sook; Kim, Jin So |
|
Sep 30, 2019 |
5410 |
| Haplotypes of HTRA1 rs1120638, TIMP3 rs9621532, VEGFA rs833068, CFI rs10033900, ERCC6 rs3793784, and KCTD10 rs56209061 Gene Polymorphisms in Age-Related Macular Degeneration. |
Liutkeviciene, Rasa; Vilkeviciute, Alvita; Gedvilaite, Greta; Kaikaryte, Kriste; Kriauciuniene, Lore |
|
Sep 30, 2019 |
8874 |
| Boehringer Ingelheim--Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases--20/9/2019. |
|
|
Sep 26, 2019 |
442 |
| Study: People with AMD at Risk for Disease in the Other Eye. |
|
|
Sep 21, 2019 |
159 |
| Allergan plc (NYSE: AGN) - Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration -- 9/9/2019. |
|
|
Sep 18, 2019 |
515 |
| Apellis announces publication of efficacy, safety data of intravitreal APL-2. |
|
Clinical report |
Sep 18, 2019 |
354 |
| Allergan plc (NYSE: AGN) - Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration -- 9/9/2019. |
|
|
Sep 17, 2019 |
515 |
| Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301. |
|
|
Sep 15, 2019 |
145 |
| Adverum Shares Sink After Phase 1 Readout From Wet AMD Gene Therapy Trial. |
|
|
Sep 12, 2019 |
393 |
| Allergan plc (NYSE: AGN) - Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration -- 9/9/2019. |
|
|
Sep 11, 2019 |
515 |
| Age-Related Macular Degeneration Market 2019 Receives a Rapid Boost in Economy due to High Emerging Demands and reach USD 11,186.8 Million by Forecast to 2023. |
|
|
Sep 9, 2019 |
830 |
| Clearside Biomedical Shares Rebound On Microinjector Licensing Deal With Regenxbio. |
|
|
Sep 4, 2019 |
400 |
| Regenxbio announces exclusive license agreement with Clearside Biomedical. |
|
|
Sep 4, 2019 |
360 |
| Bumrungrad Hospital introduces innovative ophthalmic surgical technology. |
|
|
Sep 2, 2019 |
1473 |
| Detection of Multi-Class Retinal Diseases Using Artificial Intelligence: An Expeditious Learning Using Deep CNN with Minimal Data. |
Karthikeyan, S.; Kumar, P. Sanjay; Madhusudan, R.J.; Sundaramoorthy, S.K.; Namboori, P.K. Krishnan |
|
Sep 1, 2019 |
3252 |
| SUPPLEMENTATION WITH THREE MACULAR CAROTENOIDS IN PATIENTS WITH EARLY STAGE AGE-RELATED MACULAR DEGENERATION/SUPLEMENTACIJA UPOTREBOM TRIMA MAKULARNA KAROTENOIDA KOD PACIJENATA SA RANIM STADIJUMOM SENILNE DEGENERACIJE MAKULE. |
Jovanovic, Sandra; Davidovic, Sofija; Miljkovic, Aleksandar; Krstonosic, Milica Atanackovic; Sazdani |
Clinical report |
Sep 1, 2019 |
4075 |
| Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration. |
Karacorlu, Murat; Hocaoglu, Mumin; Arf, Serra; Ersoz, M. Giray; Muslubas, Isil Sayman |
|
Sep 1, 2019 |
9577 |
| Healthy diet may lower eye disease risk: Study. |
|
|
Sep 1, 2019 |
273 |
| Eccentric viewing: This article outlines a step-by-step process to teach patients with macular disease how to make the most of their vision by using eccentric viewing techniques. |
Kumar, Narendra |
|
Sep 1, 2019 |
2740 |
| Protect Against Age-Related Vision Loss. |
Downey, Michael |
|
Sep 1, 2019 |
2843 |
| Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment. |
Hagbi-Levi, Shira; Abraham, Michal; Tiosano, Liran; Rinsky, Batya; Grunin, Michelle; Eizenberg, Orly |
|
Aug 31, 2019 |
8824 |
| N-Acetyl-L-cysteine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage: Implications for Age-Related Macular Degeneration. |
Terluk, Marcia R.; Ebeling, Mara C.; Fisher, Cody R.; Kapphahn, Rebecca J.; Yuan, Ching; Kartha, Ree |
|
Aug 31, 2019 |
9890 |
| Iconic Therapeutics enters into ophthalmology option agreement with Novartis. |
|
|
Aug 22, 2019 |
124 |
| Iconic Therapeutics enters into ophthalmology option agreement with Novartis. |
|
|
Aug 22, 2019 |
120 |
| Graybug Vision receives USD80m Series C financing. |
|
|
Aug 22, 2019 |
166 |
| Graybug Vision receives USD80m Series C financing. |
|
|
Aug 22, 2019 |
162 |
| Vehicle exhaust pollutants may lead to common eye condition. |
|
|
Aug 21, 2019 |
512 |
| Exposure to Air Pollutants May Up Risk for Macular Degeneration; Risk for age-related macular degeneration greater in highest versus lowest quartiles of NO2, CO. |
|
|
Aug 21, 2019 |
210 |
| Smoggy Air Might Contribute to Macular Degeneration. |
|
|
Aug 21, 2019 |
559 |
| High Levels Of Vehicle Pollution Exposure May Affect Central Vision, Study Says. |
|
|
Aug 21, 2019 |
502 |
| Aerie Pharma behins patient dosing in clinical trial of AR-13503 SR implant. |
|
Clinical report |
Aug 20, 2019 |
137 |
| Regeneron Pharmaceuticals Inc wins US FDA approval for the EYLEA Injection prefilled syringe for macular degeneration and macular edema. |
|
|
Aug 14, 2019 |
297 |
| Regeneron Pharmaceuticals Inc wins US FDA approval for the EYLEA Injection prefilled syringe for macular degeneration and macular edema. |
|
|
Aug 14, 2019 |
293 |
| Lineage Cell Therapeutics Awarded NIH Grant for Innovative Vision Restoration Program. |
|
|
Aug 14, 2019 |
512 |
| Regeneron's Eylea Prefilled Syringe Clears FDA Hurdle. |
|
|
Aug 13, 2019 |
280 |
| Carotenoids Market Inclinations Exhibit Growing Demand during the Period until 2018 to 2027. |
|
|
Aug 8, 2019 |
998 |
| Age-Related Macular Degeneration Market Size and share with Innovative Technologies, Key Players and their core competencies by 2023. |
|
|
Aug 8, 2019 |
916 |
| Carotenoids Market Inclinations Exhibit Growing Demand during the Period until 2018 to 2027. |
|
|
Aug 7, 2019 |
1012 |
| Experiencing the value of charitable eye care support first hand has been a reminder of the impact sight loss has on families. |
Jones, Kathy |
|
Aug 1, 2019 |
395 |
| Retinal fluid and cysts. |
Epshtein, Daniel |
|
Aug 1, 2019 |
685 |
| Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic. |
Nemcansky, Jan; Stepanov, Alexandr; Koubek, Michal; Veith, Miroslav; Klimesova, Yun Min; Studnicka, |
Clinical report |
Jul 31, 2019 |
4406 |
| Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration. |
Stattin, Martin; Forster, Julia; Daniel, Ahmed; Graf, Alexandra; Krepler, Katharina; Ansari-Shahreza |
|
Jul 31, 2019 |
4658 |
| Repressed Wnt Signaling Accelerates the Aging Process in Mouse Eyes. |
Zhang, Yujin; Jeffrey, Joseph; Dong, Fei; Zhang, Jianhua; Kao, Winston W.-Y.; Liu, Chia-Yang; Yuan, |
|
Jul 31, 2019 |
6608 |
| ROCK Inhibitor-Induced Promotion of Retinal Pigment Epithelial Cell Motility during Wound Healing. |
Kamao, Hiroyuki; Miki, Atsushi; Kiryu, Junichi |
|
Jul 31, 2019 |
6376 |
| Dosing Begins In Phase 1/2a Study Of Treatment For Dry-AMD. |
|
Clinical report |
Jul 29, 2019 |
520 |
| Kodiak Sciences announces interim data from ongoing Phase 1B study of KSI-301. |
|
|
Jul 28, 2019 |
377 |
| Event to gauge interest in setting up group; HEALTH. |
|
|
Jul 20, 2019 |
269 |
| CDC Assesses Burden of Eye Disorders in Adults With Diabetes; Cataracts found to be most commonly reported eye disorder affecting adults aged ≥45 years with diabetes. |
|
|
Jul 18, 2019 |
257 |
| Blind veteran gets artistic; Health: Ex-Royal Horse Guards serviceman got to work as sight began to fail. |
|
|
Jul 16, 2019 |
368 |
| Role of immune cells in macular scarring explored. |
Powell, Selina |
|
Jul 1, 2019 |
254 |
| Autophagy Dysfunction, Cellular Senescence, and Abnormal Immune-Inflammatory Responses in AMD: From Mechanisms to Therapeutic Potential. |
Wang, Shoubi; Wang, Xiaoran; Cheng, Yaqi; Ouyang, Weijie; Sang, Xuan; Liu, Jiahui; Su, Yaru; Liu, Yi |
|
Jun 30, 2019 |
10403 |
| Should I Take a Lutein Supplement? Lutein has been studied for its potential benefits in eye health. |
Schroeder, Natalia |
Report |
Jun 22, 2019 |
465 |
| Ophthalmic Lasers Market -- Assessment Covering Growth Factors and Upcoming Trends by 2024 End. |
|
|
Jun 19, 2019 |
913 |
| Ophthalmic Lasers Market -- Assessment Covering Growth Factors and Upcoming Trends by 2024 End. |
|
|
Jun 18, 2019 |
926 |
| Blind D-Day veteran appeals for return of treasured war medal; AWARD. |
|
|
Jun 14, 2019 |
278 |
| Adverum doses first patient in second cohort of OPTIC Phase 1 trial. |
|
|
Jun 10, 2019 |
229 |
| PROVISIONS FOR BLIND VOTERS UNLAWFUL. |
|
|
Jun 1, 2019 |
392 |
| RAD51B (rs8017304 and rs2588809), TRIB1 (rs6987702, rs4351379, and rs4351376), COL8A1 (rs13095226), and COL10A1 (rs1064583) Gene Variants with Predisposition to Age-Related Macular Degeneration. |
Vilkeviciute, Alvita; Kriauciuniene, Loresa; Chaleckis, Romanas; Deltuva, Vytenis Pranas; Liutkevici |
|
May 31, 2019 |
5821 |
| Regenxbio completes dosing for Phase I/IIa clinical trial of RGX-314. |
|
|
May 30, 2019 |
142 |
| 5 Steps to Lower Your Risk of Eye Disease. |
|
|
May 23, 2019 |
810 |
| Encouraging Results From OpRegen Phase 1/2a Clinical Study Presented. |
|
Clinical report |
May 20, 2019 |
316 |
| Adverum Biotechnologies announces lift of clinical hold on ADVM-022. |
|
|
May 16, 2019 |
246 |
| Data From Dry AMD Study Presented At ARVO. |
|
Clinical report |
May 6, 2019 |
352 |
| Support group launched. |
|
|
May 6, 2019 |
128 |
| BioTime presents updated data from OpRegen Phase I/IIa clinical study. |
|
Clinical report |
May 2, 2019 |
489 |
| Vision Health: Clear Opportunities for Market Development: Nutrition has a leading role to play in protecting eyes against modern lifestyle challenges. |
Moloughney, Sean |
|
May 1, 2019 |
3184 |
| Current Approaches to Low Vision (Re)Habilitation. |
Altinbay, Deniz; Idil, Sefay Aysun |
|
May 1, 2019 |
6173 |
| Automated Detection of Macular Diseases by Optical Coherence Tomography and Artificial Intelligence Machine Learning of Optical Coherence Tomography Images. |
Kuwayama, Soichiro; Ayatsuka, Yuji; Yanagisono, Daisuke; Uta, Takaki; Usui, Hideaki; Kato, Aki; Taka |
|
Apr 30, 2019 |
3893 |
| Antimycin A-Induced Mitochondrial Damage Causes Human RPE Cell Death despite Activation of Autophagy. |
Hytti, Maria; Korhonen, Eveliina; Hyttinen, Juha M.T.; Roehrich, Heidi; Kaarniranta, Kai; Ferrington |
|
Apr 30, 2019 |
6664 |
| Dietary Polyphenols in Age-Related Macular Degeneration: Protection against Oxidative Stress and Beyond. |
Pawlowska, Elzbieta; Szczepanska, Joanna; Koskela, Ali; Kaarniranta, Kai; Blasiak, Janusz |
|
Apr 30, 2019 |
10232 |
| BioTime To Present Data From Dry AMD Study At ARVO. |
|
Clinical report |
Apr 29, 2019 |
360 |
| BioTime To Present Data From Dry AMD Study At ARVO. |
|
Clinical report |
Apr 29, 2019 |
360 |
| Belite Bio wins US FDA approval for LBS-008 IND for macular degeneration and Stargardt disease. |
|
|
Apr 25, 2019 |
203 |
| Belite Bio wins US FDA approval for LBS-008 IND for macular degeneration and Stargardt disease. |
|
|
Apr 25, 2019 |
199 |
| US FDA accepts Novartis' biologics license application for brolucizumab. |
|
|
Apr 18, 2019 |
199 |
| Innovent Biologics Inc doses first wet AMD patient in Phase I trial of IBI302. |
|
|
Apr 18, 2019 |
245 |
| US FDA accepts Novartis' biologics license application for brolucizumab. |
|
|
Apr 18, 2019 |
195 |
| Innovent Biologics Inc doses first wet AMD patient in Phase I trial of IBI302. |
|
|
Apr 18, 2019 |
241 |
| Don't take leave of your senses; Studies show our senses dull as we age. Fiona Duffy seeks out easy ways you can protect and preserve your sight, hearing, smell, taste and touch. |
|
|
Apr 16, 2019 |
1260 |
| Don't take leave your senses; Studies show our senses dull as we age. Fiona Duffy seeks out easy ways you can protect and preserve your sight, hearing, smell, taste and touch. |
|
|
Apr 16, 2019 |
1247 |
| Novartis submits brolucizumab (RTH258) NDA with the US FDA under priority review for treating patients with wet AMD. |
|
|
Apr 16, 2019 |
291 |
| Novartis submits brolucizumab (RTH258) NDA with the US FDA under priority review for treating patients with wet AMD. |
|
|
Apr 16, 2019 |
287 |
| Adverum Biotechnologies announces clinical hold on ADVM-022 IND. |
|
|
Apr 15, 2019 |
182 |
| Novartis says FDA accepts BLA for brolucizumab for AMD treatment. |
|
|
Apr 15, 2019 |
119 |
| TV DOT GOING BLIND; Enders star June has eye condition& can't recognise her friends; EXCLUSIVE. |
|
|
Apr 6, 2019 |
111 |
| Shorts. |
Klotter, Jule |
|
Apr 1, 2019 |
2316 |
| "World's first" AMD gene therapy carried out by Oxford researchers. |
Powell, Selina |
|
Apr 1, 2019 |
227 |
| Patients need to be given clear advice and be involved in decisions about their care. |
Mackie, Scott |
|
Apr 1, 2019 |
618 |
| Biotime To Present New Data From RPE Transplant Therapy Programs. |
|
|
Mar 4, 2019 |
400 |
| Biotime To Present New Data From RPE Transplant Therapy Programs. |
|
|
Mar 4, 2019 |
400 |
| Patient outcomes: How OCT devices are helping to detect eye conditions. |
Terry, Louise |
|
Mar 1, 2019 |
404 |
| Optical Coherence Tomography Characteristics of Quiescent Type 1 Neovascularization in Eyes with Nonexudative Age-related Macular Degeneration. |
Mentes, Jale; Yildirim, Seyda |
|
Mar 1, 2019 |
2201 |
| BioTime to present new data from OpRegen program at ARVO 2019. |
|
|
Feb 26, 2019 |
229 |
| Piper increasingly confident in Adverum's wet AMD study. |
|
|
Feb 25, 2019 |
113 |
| Ocular Therapeutix Doses First Patient in OTX-TKI Phase 1 Clinical Trial for the Treatment of Wet Age-related Macular Degeneration. |
|
|
Feb 22, 2019 |
398 |
| B+L launches SightMatters.com. |
|
|
Feb 18, 2019 |
419 |
| NICE Guideline 82: what does it mean for practitioners? |
Hazel, Charlotte A. |
|
Feb 1, 2019 |
3031 |
| Melatonin Isn't Just for Sleeping--From Cardiovascular Disease and Cancer to Aging and Macular Degeneration the Research Will Shock You. |
Shallenberger, Frank |
Report |
Feb 1, 2019 |
6877 |
| Rescuing Photoreceptors, Preventing Blindness Caused By AMD: Clinical Trial Of Stem Cell-Based Therapy In The Works. |
|
|
Jan 28, 2019 |
621 |
| Research Roundup. |
|
|
Jan 1, 2019 |
307 |
| Mediterranean Diet Benefits Eye Health: Research suggests the diet may confer protection against a major cause of blindness in seniors. |
|
|
Jan 1, 2019 |
992 |
| First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration. |
Sul, Sabahattin; Karalezli, Aylin; Karabulut, Mujdat |
|
Jan 1, 2019 |
3027 |
| Clinical application of multicolor optical coherence tomography in the diagnosis of retinal pathologies. |
|
|
Dec 31, 2018 |
2871 |
| Stealth BioTherapeutics wins US FDA FTD for elamipretide to treat dry age-related macular degeneration. |
|
|
Dec 11, 2018 |
219 |
| Stealth BioTherapeutics wins US FDA FTD for elamipretide to treat dry age-related macular degeneration. |
|
|
Dec 11, 2018 |
215 |
| CrowdReviews Partnered with Conference Series to Announce: CME Accredited 28th International Conference on Insights in Ophthalmology. |
|
Conference news |
Dec 7, 2018 |
589 |
| Adverum Biotechnologies announces publication of ADVM-022 data. |
|
|
Dec 3, 2018 |
161 |
| An Orange a Day to Keep AMD Away: A new study finds that people who eat oranges have a lower risk of developing macular degeneration. |
|
|
Dec 1, 2018 |
484 |
| Protect Your Eyes. |
Hadziahmetovic, Majda |
|
Dec 1, 2018 |
197 |
| Saffron therapy for the treatment of mild/moderate age-related macular degeneration. |
McLean, Wendy |
Author abstract |
Dec 1, 2018 |
541 |
| Ophthotech Releases Results from Phase 2a Safety Trial of Zimura in Combination with Lucentis in Wet Age-Related Macular Degeneration. |
|
|
Nov 16, 2018 |
850 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Nov 14, 2018 |
823 |
| Ophthotech announces results from Phase 2a safety trial of Zimura. |
|
Financial report |
Nov 12, 2018 |
749 |
| Oncobiologics advances ONS-5010 into wet AMD clinical trial. |
|
|
Nov 6, 2018 |
154 |
| Oxurion and Beta Therapeutics enter into strategic research collaboration for development of new heparanase inhibitors to treat retinal disorders. |
|
|
Nov 6, 2018 |
360 |
| Oxurion and Beta Therapeutics enter into strategic research collaboration for development of new heparanase inhibitors to treat retinal disorders. |
|
|
Nov 6, 2018 |
356 |
| Dry eye market demographic expands to all ages. |
|
|
Nov 5, 2018 |
1958 |
| WET AMD DRUG RULING. |
|
Brief article |
Nov 1, 2018 |
149 |
| Treat your AMD patients as you would a family member with AMD. |
Sherman, Jerome; Epshtein, Daniel |
|
Nov 1, 2018 |
3177 |
| Research Roundup. |
|
Brief article |
Nov 1, 2018 |
315 |
| Mediterranean-Style Diet May Benefit Eye Health. |
|
|
Nov 1, 2018 |
161 |
| Ophthotech acquires Versant Ventures' Inception 4. |
|
|
Oct 31, 2018 |
198 |
| New Stairway Study Data Shows Potential for Extended Durability with Faricimab in Wet Age-Related Macular Degeneration. |
|
|
Oct 30, 2018 |
409 |
| Seeing More Than Before. |
|
|
Oct 27, 2018 |
363 |
| Compact Imaging, Novartis Pharma collaborate to develop home monitor for AMD, DR. |
|
|
Oct 25, 2018 |
312 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 23, 2018 |
837 |
| Eating leafy greens could prevent vision loss. |
|
|
Oct 22, 2018 |
421 |
| Eating Spinach, Beetroot Could Help Prevent Vision Loss. |
|
|
Oct 22, 2018 |
245 |
| $1.5M Grant To Advance Canadian Scientist's Vision Loss Research. |
|
|
Oct 22, 2018 |
329 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 20, 2018 |
820 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 18, 2018 |
835 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 16, 2018 |
838 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES,LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 16, 2018 |
1055 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 16, 2018 |
838 |
| Why it's crucial to keep an eye on your health; FROM SIGHT LOSS TO SERIOUS HEALTH ISSUES, LIZ CONNOR FINDS OUT HOW EYE TESTS CAN REVEAL MORE THAN JUST VISION PROBLEMS. |
|
|
Oct 16, 2018 |
838 |
| $1.5M Grant Will Advance Canadian Scientist's Vision Loss Research. |
|
|
Oct 15, 2018 |
299 |
| $1.5M Grant Will Advance Canadian Scientist's Vision Loss Research. |
|
|
Oct 15, 2018 |
300 |
| Ionis Pharmaceuticals receives $75M payment from Roche to develop IONIS-FB-LRx. |
|
|
Oct 10, 2018 |
200 |
| Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration. |
|
|
Oct 5, 2018 |
518 |
| Association between Age-Related Macular Degeneration and Lens Opacity in Senior Population in Hainan Province. |
Zhang, Kai-Yan; Zhong, Qiong-Lei; Xu, Yan; Guo, Chuan-Xian; Chen, Si-Ying; Yan, Yi-Jie; Wu, Xiao-Lin |
Letter to the editor |
Oct 5, 2018 |
1047 |
| A PS1.3 million victory for common sense. |
|
|
Oct 4, 2018 |
703 |
| Ophthotech completes patient recruitment for Phase 2b clinical trial of Zimura. |
|
|
Oct 4, 2018 |
105 |
| Regenxbio completes dosing fourth cohort in Phase 1 trial of wet AMD candidate. |
|
|
Oct 4, 2018 |
126 |
| Adherence to Mediterranean Diet Linked to Lower Risk for AMD; Adults with high versus low MeDi score have lower risk for advanced age-related macular degeneration. |
|
Clinical report |
Oct 4, 2018 |
216 |
| Literature Review & Commentary. |
Gaby, Alan R. |
|
Oct 1, 2018 |
2288 |
| Mediterranean-Style Diet May Slow Progress of Eye Disease. |
|
|
Oct 1, 2018 |
154 |
| Legal ruling means NHS patients will get eye drug. |
|
|
Sep 27, 2018 |
485 |
| Doctor survey shows Allergan could be big player in wet-AMD, says Deutsche Bank. |
|
|
Sep 12, 2018 |
116 |
| Your eyes as you age: Reduce the risk of age-related macular degeneration. |
|
|
Sep 8, 2018 |
315 |
| What You Must Know About Age-Related Macular Degeneration. |
Bethany, Susan |
Book review |
Sep 1, 2018 |
445 |
| Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1. |
Ozkaya, Abdullah; Karabas, Levent; Alagoz, Cengiz; Alkin, Zeynep; Artunay, Ozgur; Bolukbasi, Selim; |
Report |
Sep 1, 2018 |
4828 |
| Evaluation of the Relationship Between Age-related Macular Degeneration and Refractive Error, Socio-demographic Features, and Biochemical Variables in a Turkish Population. |
Yurtseven, Oznur Gurbuz; Aksoy, Sibel; Arsan, Aysu Karatay; Ozkurt, Yelda Buyru; Kokcen, Hatice Kubr |
|
Sep 1, 2018 |
4760 |
| World Senior Citizens Day: AMD, leading cause of chronic blindness in elderly. |
|
|
Aug 21, 2018 |
404 |
| FDA Approves Eylea Injection sBLA in Wet Age-related Macular Degeneration. |
|
|
Aug 21, 2018 |
219 |
| Regeneron Pharmaceuticals Inc passes US FDA approval for EYLEA (aflibercept) Injection sBLA in wet AMD. |
|
|
Aug 20, 2018 |
214 |
| Regeneron Pharmaceuticals Inc passes US FDA approval for EYLEA (aflibercept) Injection sBLA in wet AMD. |
|
|
Aug 20, 2018 |
218 |
| Congenital Blindness Reversed in Mice. |
|
|
Aug 20, 2018 |
655 |
| SEE BLIND MICE.. Stem cell 'first' gives hope of curing vision loss in humans. |
|
|
Aug 17, 2018 |
176 |
| Blindness could be reversible: Scientists give mice back its vision. |
|
|
Aug 16, 2018 |
725 |
| Regeneron Provides Regulatory Update on Eylea Injection sBLA in Wet Age-Related Macular Degeneration. |
|
|
Aug 15, 2018 |
303 |
| Exposure to blue light from smartphones, laptops can cause eye problems. |
|
|
Aug 14, 2018 |
437 |
| Blue light accelerates blindness: Study. |
|
|
Aug 11, 2018 |
382 |
| Blue light accelerates blindness: Study. |
|
|
Aug 11, 2018 |
378 |
| Study finds link between eye diseases and Alzheimer's. |
|
|
Aug 8, 2018 |
385 |
| Aerie Pharmaceuticals and DSM Biomedical expand collaboration agreement. |
|
|
Aug 1, 2018 |
232 |
| Adverum Biotechnologies announces progress across gene therapy pipeline. |
|
|
Aug 1, 2018 |
182 |
| Can Leafy Greens Protect Eyes From Disease? |
Moss, Brion W. |
|
Aug 1, 2018 |
1301 |
| RESEARCH COULD END INJECTIONS FOR AMD. |
|
Brief article |
Aug 1, 2018 |
261 |
| Pigment dispersion, pseudoexfoliation syndromes and glaucoma. |
Keys, Stanley |
|
Aug 1, 2018 |
2864 |
